BrightSpring Health Services, Inc. Common Stock
NASDAQ:BTSGMedical - Healthcare Information Services
+$0.29 today
- Market cap
- $13.60B
- Beta
- 1.87
- P/E (TTM)
- 56.0
- EPS (TTM)
- $1.15
Volume 1.77M
Average 2.99M
BTSG Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
BrightSpring Health Services, Inc. Common StockNASDAQ: BTSG
Revenue · Q3 FY2026 · quarter ended Sep 2026
Revenue growth accelerates
Q3 FY2026 revenue of $4.21B rose 26.4% year over year, ahead of the +22.9% change in trailing-twelve-month revenue. Sequentially, it rose 8.8% from the prior quarter. Over 3 fiscal years it compounded at +18.7% a year.
Context
- Revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 13 analysts of $16.01B (+24.0%) for the fiscal year ending Dec 2026, a step up from the +14.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $4.21B+8.8% QoQ
- Last fiscal yearDec 2025
- $12.91B+14.6% YoY
- LTMSep 2026
- $15.25B+22.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +26.4% | +22.5% | -3.8 pp |
| 1 year | +14.6% | +24.0% | +9.4 pp |
| 3-year CAGR | +18.7% | +17.8% | -0.9 pp |
| 5-year CAGR | +20.0% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 12.91B USD
- Year-over-year change
- +14.6%
- 4-year CAGR
- +17.8%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 12.91B | +14.6% |
| FY2024 | 2024-12-31 | 11.27B | +27.6% |
| FY2023 | 2023-12-31 | 8.83B | +14.3% |
| FY2022 | 2022-12-31 | 7.72B | +15.3% |
| FY2021 | 2021-12-31 | 6.7B | — |
Revenue vs competitors
How BTSG compares with its peers on the latest reported figures
- BTSG's LTM Sep 2026 revenue of $15.25B is the highest of the 4 companies compared; the peer median is $2.6B.
- Its year-over-year change of +22.9% is the 2nd highest of 4, against a peer median of +20.4%.
- Over three fiscal years its annual growth of +18.7% compares with a peer median of +18.3%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | $15.25B | +22.9% | +18.7% | |
| LTM Sep 2026 | $2.87B | +29.8% | +64.5% | |
| LTM Jun 2026 | $2.6B | +3.3% | +5.8% | |
| LTM Jun 2026 | $1.58B | +20.4% | +18.3% | |
| Peer median (excluding BTSG) | $2.6B | +20.4% | +18.3% | |
Competitors are the stored peer set for BTSG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 6.7B | 7.72B | 8.83B | 11.27B | 12.91B |
| Cost of Revenue | 5.45B | 6.37B | 7.39B | 9.68B | 11.39B |
| Gross Profit | 1.25B | 1.35B | 1.43B | 1.59B | 1.52B |
| Gross Margin | 18.6% | 17.5% | 16.2% | 14.1% | 11.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.01B | 1.13B | 1.29B | 1.38B | 1.22B |
| Operating Expenses | 1.01B | 1.17B | 1.29B | 1.38B | 1.22B |
| Depreciation & Amortization | 199.16M | 203.97M | 202.34M | 204.48M | 164.28M |
| EBITDA | 433.34M | 391.8M | 349.52M | 398.13M | 459.53M |
| EBITDA Margin | 6.5% | 5.1% | 4.0% | 3.5% | 3.6% |
| Operating Income | 234.18M | 187.83M | 147.18M | 206.37M | 295.25M |
| Operating Margin | 3.5% | 2.4% | 1.7% | 1.8% | 2.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 165.32M | 233.58M | 324.59M | 228.39M | 157.31M |
| Other Income / Expenses | (165.32M) | (233.58M) | (324.59M) | (241.11M) | (157.31M) |
| Income Before Tax | 68.86M | (45.75M) | (177.41M) | (34.74M) | 137.94M |
| Pre-Tax Margin | 1.0% | -0.6% | -2.0% | -0.3% | 1.1% |
| Income Tax Expense | 17.6M | 8.47M | (20.58M) | (14.22M) | 33.15M |
| Net Income | 49.8M | (53.91M) | (154.6M) | (18.06M) | 190.67M |
| Net Margin | 0.7% | -0.7% | -1.8% | -0.2% | 1.5% |
| EPS (Basic) | 0.29 | (0.31) | (0.90) | (0.09) | 0.94 |
| EPS (Diluted) | 0.29 | (0.31) | (0.90) | (0.09) | 0.87 |
| Weighted Avg Shares | 171.19M | 171.19M | 171.19M | 193M | 202.56M |
| Weighted Avg Shares (Diluted) | 171.19M | 171.19M | 171.19M | 193M | 219.77M |
BrightSpring Health Services, Inc. Common Stock
NASDAQ:BTSG
Intrinsic Alpha fair value
Locked
Current Price
$68.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.